GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Upstream Bio Inc (NAS:UPB) » Definitions » PB Ratio

UPB (Upstream Bio) PB Ratio : 1.08 (As of Mar. 17, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Upstream Bio PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-17), Upstream Bio's share price is $9.495. Upstream Bio's Book Value per Share for the quarter that ended in Dec. 2024 was $8.77. Hence, Upstream Bio's PB Ratio of today is 1.08.

The historical rank and industry rank for Upstream Bio's PB Ratio or its related term are showing as below:

UPB' s PB Ratio Range Over the Past 10 Years
Min: 0.87   Med: 1.1   Max: 2.09
Current: 1.08

During the past 3 years, Upstream Bio's highest PB Ratio was 2.09. The lowest was 0.87. And the median was 1.10.

UPB's PB Ratio is ranked better than
75.68% of 1279 companies
in the Biotechnology industry
Industry Median: 2.35 vs UPB: 1.08

Back to Basics: PB Ratio


Upstream Bio PB Ratio Historical Data

The historical data trend for Upstream Bio's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Upstream Bio PB Ratio Chart

Upstream Bio Annual Data
Trend Dec22 Dec23 Dec24
PB Ratio
- - 1.88

Upstream Bio Quarterly Data
Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial - - - - 1.88

Competitive Comparison of Upstream Bio's PB Ratio

For the Biotechnology subindustry, Upstream Bio's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Upstream Bio's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Upstream Bio's PB Ratio distribution charts can be found below:

* The bar in red indicates where Upstream Bio's PB Ratio falls into.



Upstream Bio PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Upstream Bio's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=9.495/8.765
=1.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Upstream Bio  (NAS:UPB) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Upstream Bio PB Ratio Related Terms

Thank you for viewing the detailed overview of Upstream Bio's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Upstream Bio Business Description

Traded in Other Exchanges
N/A
Address
890 Winter Street, Suite 200, Waltham, MA, USA, 02451
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases.